Scherl, E., Jacobstein, D., Murphy, C., Ott, E., Gasink, C., Baumgart, D. C., & Abraham, B. (2018). A109 PREGNANCY OUTCOMES IN WOMEN EXPOSED TO USTEKINUMAB IN THE CROHN’S DISEASE CLINICAL DEVELOPMENT PROGRAM. J Can Assoc Gastroenterol.
Chicago-стиль цитированияScherl, E., D. Jacobstein, C. Murphy, E. Ott, C. Gasink, D C. Baumgart, and B. Abraham. "A109 PREGNANCY OUTCOMES IN WOMEN EXPOSED TO USTEKINUMAB IN THE CROHN’S DISEASE CLINICAL DEVELOPMENT PROGRAM." J Can Assoc Gastroenterol 2018.
MLA-цитированиеScherl, E., et al. "A109 PREGNANCY OUTCOMES IN WOMEN EXPOSED TO USTEKINUMAB IN THE CROHN’S DISEASE CLINICAL DEVELOPMENT PROGRAM." J Can Assoc Gastroenterol 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.